Shares of Pharming Group (OTCMKTS:PHGUF – Get Free Report) traded down 4% during trading on Monday . The stock traded as low as $0.82 and last traded at $0.82. 200 shares traded hands during trading, a decline of 94% from the average session volume of 3,522 shares. The stock had previously closed at $0.86.
Pharming Group Stock Performance
The stock has a 50 day moving average price of $0.78 and a two-hundred day moving average price of $0.85. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.53 and a quick ratio of 2.76. The company has a market capitalization of $536.67 million, a price-to-earnings ratio of -41.13 and a beta of 1.18.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Further Reading
- Five stocks we like better than Pharming Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Intel: Is Now the Time to Be Brave?Â
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- ETF Screener: Uses and Step-by-Step Guide
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
